RCA Micro vs Resound Vivia 9 60S microRIE

The RCA Micro is a budget-priced behind-the-ear OTC hearing aid available for $399. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, placing it at #65 of 65 devices in the OTC Hearing Aid category. Speech performance represents the most significant limitation of this device. Speech in Quiet scores 1.0/5, which is 1.79 points below the category average, while Speech in Noise also scores 1.0/5, falling 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in our standardized test conditions. The RCA Micro does excel in one area: feedback handling earns an excellent 5.0/5, which is 0.46 points above the category average. This suggests stable performance without whistling during typical use. Own Voice comfort scores a mixed 2.1/5, sitting 0.41 points below average. Music Streaming scores 0.0/5, falling 1.92 points below the category average, indicating this device is not suitable for audio entertainment. At this price point, several alternatives offer substantially stronger performance. The Elehear Beyond, Apple AirPods Pro 2, and Zepp Clarity Omni all score above 3.8/5 in the same price range. Consumers prioritizing speech clarity and overall sound quality should consider these higher-performing options. The RCA Micro may appeal to those who need basic amplification with reliable feedback control and prefer a simple rechargeable behind-the-ear design.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.